ROCKWELL MEDICAL, INC.: common shares outstanding

What this measure means

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Exact concept: us-gaap:CommonStockSharesOutstanding. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• ROCKWELL MEDICAL, INC.: total assets
• ROCKWELL MEDICAL, INC.: total liabilities
• ROCKWELL MEDICAL, INC.: stockholders equity
• ROCKWELL MEDICAL, INC.: cash and cash equivalents
• ROCKWELL MEDICAL, INC.: net income or loss
• ROCKWELL MEDICAL, INC.: operating cash flow
• ROCKWELL MEDICAL, INC.: financing cash flow
• ROCKWELL MEDICAL, INC.: investing cash flow
• ROCKWELL MEDICAL, INC.: retained earnings or deficit
• ROCKWELL MEDICAL, INC.: basic weighted-average shares
• ROCKWELL MEDICAL, INC.: diluted weighted-average shares
• ROCKWELL MEDICAL, INC.: basic earnings per share
• ROCKWELL MEDICAL, INC.: diluted earnings per share
• ROCKWELL MEDICAL, INC.: income tax expense or benefit
• ROCKWELL MEDICAL, INC.: net property, plant and equipment
• ROCKWELL MEDICAL, INC.: share-based compensation expense
• ROCKWELL MEDICAL, INC.: operating income or loss
• ROCKWELL MEDICAL, INC.: current assets
• ROCKWELL MEDICAL, INC.: interest expense
• ROCKWELL MEDICAL, INC.: current liabilities
• ROCKWELL MEDICAL, INC.: current accounts payable
• ROCKWELL MEDICAL, INC.: goodwill carrying amount
• ROCKWELL MEDICAL, INC.: net current accounts receivable
• ROCKWELL MEDICAL, INC.: net inventory
• ROCKWELL MEDICAL, INC.: gross profit
• ROCKWELL MEDICAL, INC.: selling, general and administrative expense
• ROCKWELL MEDICAL, INC.: research and development expense
• ROCKWELL MEDICAL, INC.: cash including restricted cash
• ROCKWELL MEDICAL, INC.: additional paid-in capital
• ROCKWELL MEDICAL, INC.: accumulated other comprehensive income or loss
• ROCKWELL MEDICAL, INC.: operating lease right-of-use asset
• ROCKWELL MEDICAL, INC.: operating lease liability
• ROCKWELL MEDICAL, INC.: gross property, plant and equipment
• ROCKWELL MEDICAL, INC.: accumulated depreciation on property, plant and equipment
• ROCKWELL MEDICAL, INC.: net intangible assets excluding goodwill
• ROCKWELL MEDICAL, INC.: other noncurrent assets
• ROCKWELL MEDICAL, INC.: other noncurrent liabilities
• ROCKWELL MEDICAL, INC.: accrued current liabilities
• ROCKWELL MEDICAL, INC.: prepaid expenses and other current assets
• ROCKWELL MEDICAL, INC.: current contract liabilities
• ROCKWELL MEDICAL, INC.: pre-tax income or loss from continuing operations
• ROCKWELL MEDICAL, INC.: comprehensive income or loss
• ROCKWELL MEDICAL, INC.: net income available to common stockholders
• ROCKWELL MEDICAL, INC.: general and administrative expense
• ROCKWELL MEDICAL, INC.: depreciation expense
• ROCKWELL MEDICAL, INC.: depreciation, depletion and amortization
• ROCKWELL MEDICAL, INC.: nonoperating interest expense
• ROCKWELL MEDICAL, INC.: other nonoperating income or expense
• ROCKWELL MEDICAL, INC.: interest paid, net
• ROCKWELL MEDICAL, INC.: proceeds from issuing common stock
• ROCKWELL MEDICAL, INC.: operating lease payments
• ROCKWELL MEDICAL, INC.: change in accounts receivable
• ROCKWELL MEDICAL, INC.: change in inventories
• ROCKWELL MEDICAL, INC.: change in accounts payable

Inspect the source

Entity

ROCKWELL MEDICAL, INC. / CIK 0001041024

Captured

2026-09-20T05:15:52.429Z

SEC response SHA-256

88e8b83e4e95fda016bcc9a5dced4522c975c40fff65ebdbda5ac42b28ba4fb6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001041024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))